Rani Therapeutics Holdings Inc Class A
North American company
Times are shown in GMT-4, values are delayed by at least 15 minutes. Past performance is not a reliable indicator of future results.
Rani Therapeutics Holdings Inc is a clinical stage biotherapeutics company advancing technologies to enable the development of orally administered biologics. It has developed the RaniPill capsule, proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing.
Latest RANI News
Currently there are no news & analysis articles for this instrument. Visit our news hub for the latest investment news from ii and Alliance News